Join
Live feed
·
PRReleasevia Quantisnow
Ernexa Therapeutics Inc. logo

Ernexa Therapeutics Receives Independent Validation of ERNA-101 with Complete Tumor Clearance and Durable Survival in Ovarian Cancer Models Ahead of Planned Clinical Entry

ByQuantisnow·Wall Street's wire, on your screen.
ERNA· Ernexa Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ERNA (Ernexa Therapeutics Inc.) and more on Quantisnow.